Literature DB >> 28043194

Differential regulation of intestinal efflux transporters by pregnancy in mice.

Jamie E Moscovitz1, Gabriel Yarmush1, Guadalupe Herrera-Garcia2, Grace L Guo1,3, Lauren M Aleksunes1,3.   

Abstract

1. In the intestines, the nuclear receptors farnesoid X receptor (Fxr) and pregnane X receptor (Pxr) regulate the transcription of metabolizing enzymes and transporters that dictate the absorption of nutrients and xenobiotics. 2. Here, we sought to determine whether Fxr and Pxr signaling pathways are disrupted in response to high-circulating concentrations of steroid hormones late in pregnancy leading to altered transporter expression. To test this, ileum were collected from virgin and pregnant C57BL/6 mice on gestation days 14, 17 and 19. 3. Ileum from pregnant mice exhibited suppression of Fgf15 and Cyp3a11 mRNAs, which are the prototypical target genes for Fxr and Pxr, respectively. An overall reduction in the expression of apical efflux transporters, including Mdr1, Mrp2 and Bcrp, was observed in pregnant mice. To assess the ability of steroid hormones to alter intestinal nuclear receptor signaling, transporter mRNA expression was quantified in human intestinal LS174T adenocarcinoma cells. In vitro data demonstrated that progestins reduced CYP3A4, MDR1 and MRP2 mRNA expression by 30-40%. 4. These data suggest that progesterone may act as a mediator to negatively regulate efflux transporter expression in the mouse ileum during pregnancy possibly by reducing PXR/Pxr signaling. This may affect drug absorption and disposition during pregnancy.

Entities:  

Keywords:  Efflux transporters; Pxr; intestine; pregnancy; progestins

Mesh:

Substances:

Year:  2017        PMID: 28043194      PMCID: PMC5495628          DOI: 10.1080/00498254.2016.1250292

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  47 in total

1.  Progesterone and oestradiol-17beta concentrations in the peripheral plasma during pregnancy in the mouse.

Authors:  J T McCormack; G S Greenwald
Journal:  J Endocrinol       Date:  1974-07       Impact factor: 4.286

2.  Gastrointestinal transit: the effect of the menstrual cycle.

Authors:  A Wald; D H Van Thiel; L Hoechstetter; J S Gavaler; K M Egler; R Verm; L Scott; R Lester
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

3.  Effects of progesterone on gastric emptying and intestinal transit in male rats.

Authors:  Chuan-Yong Liu; Lian-Bi Chen; Pei-Yi Liu; Dong-Ping Xie; Paulus S Wang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Tissue distribution and induction of human multidrug resistant protein 3.

Authors:  George L Scheffer; Marcel Kool; Marcel de Haas; J Marleen L de Vree; Adriana C L M Pijnenborg; Diederik K Bosman; Ronald P J Oude Elferink; Paul van der Valk; Piet Borst; Rik J Scheper
Journal:  Lab Invest       Date:  2002-02       Impact factor: 5.662

5.  The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes.

Authors:  Jean-François Landrier; Jyrki J Eloranta; Stephan R Vavricka; Gerd A Kullak-Ublick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-11-03       Impact factor: 4.052

6.  The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis.

Authors:  Anuradha Rao; Jamie Haywood; Ann L Craddock; Martin G Belinsky; Gary D Kruh; Paul A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

7.  Regional variations in ABC transporter expression along the mouse intestinal tract.

Authors:  David M Mutch; Pascale Anderle; Muriel Fiaux; Robert Mansourian; Karine Vidal; Walter Wahli; Gary Williamson; Matthew-Alan Roberts
Journal:  Physiol Genomics       Date:  2004-03-12       Impact factor: 3.107

8.  Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells.

Authors:  P Martin; R Riley; D J Back; A Owen
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

9.  Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.

Authors:  Javier Vaquero; Maria J Monte; Mercedes Dominguez; Jordi Muntané; Jose J G Marin
Journal:  Biochem Pharmacol       Date:  2013-08-06       Impact factor: 5.858

10.  Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype.

Authors:  Shadi Abu-Hayyeh; Georgia Papacleovoulou; Anita Lövgren-Sandblom; Mehreen Tahir; Olayiwola Oduwole; Nurul Akmal Jamaludin; Sabiha Ravat; Vanya Nikolova; Jenny Chambers; Clare Selden; Myrddin Rees; Hanns-Ulrich Marschall; Malcolm G Parker; Catherine Williamson
Journal:  Hepatology       Date:  2013-01-08       Impact factor: 17.425

View more
  2 in total

Review 1.  An update on the physiologic changes during pregnancy and their impact on drug pharmacokinetics and pharmacogenomics.

Authors:  Ahizechukwu C Eke
Journal:  J Basic Clin Physiol Pharmacol       Date:  2021-12-08

2.  Maternal glucose homeostasis is impaired in mouse models of gestational cholestasis.

Authors:  Elena Bellafante; Saraid McIlvride; Vanya Nikolova; Hei Man Fan; Luiza Borges Manna; Jenny Chambers; Mavis Machirori; Anita Banerjee; Kevin Murphy; Marcus Martineau; Kristina Schoonjans; Hanns-Ulrich Marschall; Peter Jones; Catherine Williamson
Journal:  Sci Rep       Date:  2020-07-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.